Eiropas Savienība - bulgāru - EMA (European Medicines Agency)

novo nordisk a/s - somapacitan - Растеж - Хипофизни и хипоталамични хормони и аналози - sogroya is indicated for the replacement of endogenous growth hormone (gh) in children  aged 3  years and above, and adolescents with growth failure due to growth hormone deficiency (paediatric ghd), and in adults with growth hormone deficiency (adult ghd).

Eiropas Savienība - bulgāru - EMA (European Medicines Agency)

novo nordisk a/s - semaglutide - obesity; overweight - Препарати против затлъстяване, с изключение на тези, диетични продукти - wegovy is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial body mass index (bmi) of- ≥30 kg/m² (obesity), or- ≥27 kg/m² to.

Bulgārija - bulgāru - Изпълнителна агенция по лекарствата

0,5 mg tablets

Bulgārija - bulgāru - Изпълнителна агенция по лекарствата

0,75 mg tablets

Bulgārija - bulgāru - Изпълнителна агенция по лекарствата

1 mg tablets

Eiropas Savienība - bulgāru - EMA (European Medicines Agency)

bavarian nordic a/s - холерный вибрион, щам и ИЗРАВНИТЕЛНИТЕ 103-hgr за да живеят - холера - Ваксини - vaxchora is indicated for active immunisation against disease caused by vibrio cholerae serogroup o1 in adults and children aged 2 years and older. Тази ваксина трябва да се използва в съответствие с официалните препоръки.

Eiropas Savienība - bulgāru - EMA (European Medicines Agency)

nordic group b.v. - Метотрексат - arthritis, psoriatic; psoriasis; arthritis, juvenile rheumatoid; arthritis, rheumatoid - Антинеопластични средства - nordimet is indicated for the treatment of:active rheumatoid arthritis in adult patients,polyarthritic forms of severe, active juvenile idiopathic arthritis (jia), when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate,moderate to severe plaque psoriasis in adults who are candidates for systemic therapy, and severe psoriatic arthritis in adult patients, induction of remission in moderate steroid-dependent crohn's disease in adult patients, in combination with corticosteroids and for maintenance of remission, as monotherapy, in patients who have responded to methotrexate.

Bulgārija - bulgāru - Изпълнителна агенция по лекарствата

nordic pharma s.r.o. - Митомицин - 20 mg powder for solution for injection

Bulgārija - bulgāru - Изпълнителна агенция по лекарствата

nordic pharma s.r.o. - Митомицин - 10 mg powder for solution for injection

Bulgārija - bulgāru - Изпълнителна агенция по лекарствата

nordic group bv - лидокаин хидрохлорид - 20 mg/ml solution for injection